BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 18782656)

  • 21. Safety of adjuvant endocrine therapy in postmenopausal women with breast cancer.
    Abdulhaq H; Geyer C
    Am J Clin Oncol; 2008 Dec; 31(6):595-605. PubMed ID: 19060594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How should morning function in rheumatoid arthritis be assessed? Bibliographic study of current assessment.
    Cutolo M
    Scand J Rheumatol Suppl; 2011; 125():17-22. PubMed ID: 21529306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunological therapies can relieve aromatase inhibitor-related joint symptoms in breast cancer survivors.
    Zhang Q; Tang D; Zhao H
    Am J Clin Oncol; 2010 Dec; 33(6):557-60. PubMed ID: 20124972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Light during darkness and cancer: relationships in circadian photoreception and tumor biology.
    Jasser SA; Blask DE; Brainard GC
    Cancer Causes Control; 2006 May; 17(4):515-23. PubMed ID: 16596305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are all aromatase inhibitors alike?
    Blackwell KL
    Breast Cancer Res Treat; 2008 Dec; 112 Suppl 1():35-43. PubMed ID: 19101793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nocturnal hormones and clinical rhythms in rheumatoid arthritis.
    Cutolo M; Otsa K; Aakre O; Sulli A
    Ann N Y Acad Sci; 2005 Jun; 1051():372-81. PubMed ID: 16126979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Artificial lighting in the industrialized world: circadian disruption and breast cancer.
    Stevens RG
    Cancer Causes Control; 2006 May; 17(4):501-7. PubMed ID: 16596303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-intensity red light suppresses melatonin.
    Hanifin JP; Stewart KT; Smith P; Tanner R; Rollag M; Brainard GC
    Chronobiol Int; 2006; 23(1-2):251-68. PubMed ID: 16687299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melatonin-estrogen interactions in breast cancer.
    Sánchez-Barceló EJ; Cos S; Mediavilla D; Martínez-Campa C; González A; Alonso-González C
    J Pineal Res; 2005 May; 38(4):217-22. PubMed ID: 15813897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does the weather really matter? A cohort study of influences of weather and solar conditions on daily variations of joint pain in patients with rheumatoid arthritis.
    Smedslund G; Mowinckel P; Heiberg T; Kvien TK; Hagen KB
    Arthritis Rheum; 2009 Sep; 61(9):1243-7. PubMed ID: 19714599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melatonin, sleep disturbance and cancer risk.
    Blask DE
    Sleep Med Rev; 2009 Aug; 13(4):257-64. PubMed ID: 19095474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melatonin: new places in therapy.
    Maharaj DS; Glass BD; Daya S
    Biosci Rep; 2007 Dec; 27(6):299-320. PubMed ID: 17828452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacology of arthralgia with estrogen deprivation.
    Lintermans A; Neven P
    Steroids; 2011 Jul; 76(8):781-5. PubMed ID: 21377484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Melatonin: a hormone that modulates pain.
    Ambriz-Tututi M; Rocha-González HI; Cruz SL; Granados-Soto V
    Life Sci; 2009 Apr; 84(15-16):489-98. PubMed ID: 19223003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aromatase inhibitors: are there differences between steroidal and nonsteroidal aromatase inhibitors and do they matter?
    Miller WR; Bartlett J; Brodie AM; Brueggemeier RW; di Salle E; Lønning PE; Llombart A; Maass N; Maudelonde T; Sasano H; Goss PE
    Oncologist; 2008 Aug; 13(8):829-37. PubMed ID: 18695261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic actions of melatonin in cancer: possible mechanisms.
    Srinivasan V; Spence DW; Pandi-Perumal SR; Trakht I; Cardinali DP
    Integr Cancer Ther; 2008 Sep; 7(3):189-203. PubMed ID: 18815150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arthralgia during aromatase inhibitor treatment in early breast cancer patients: prevalence, impact, and recognition by healthcare providers.
    Boonstra A; van Zadelhoff J; Timmer-Bonte A; Ottevanger PB; Beurskens CH; van Laarhoven HW
    Cancer Nurs; 2013; 36(1):52-9. PubMed ID: 22495502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exercise intervention in breast cancer patients with aromatase inhibitor-associated arthralgia: a pilot study.
    DeNysschen CA; Burton H; Ademuyiwa F; Levine E; Tetewsky S; O'Connor T
    Eur J Cancer Care (Engl); 2014 Jul; 23(4):493-501. PubMed ID: 24289215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adaptation of an Evidence-Based Arthritis Program for Breast Cancer Survivors on Aromatase Inhibitor Therapy Who Experience Joint Pain.
    Nyrop KA; Callahan LF; Rini C; Altpeter M; Hackney B; Schecher A; Wilson A; Muss HB
    Prev Chronic Dis; 2015 Jun; 12():E91. PubMed ID: 26068412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does melatonin play a disease-promoting role in rheumatoid arthritis?
    Maestroni GJ; Cardinali DP; Esquifino AI; Pandi-Perumal SR
    J Neuroimmunol; 2005 Jan; 158(1-2):106-11. PubMed ID: 15589043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.